307 related articles for article (PubMed ID: 18762767)
1. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation.
Pullarkat V; Blanchard S; Tegtmeier B; Dagis A; Patane K; Ito J; Forman SJ
Bone Marrow Transplant; 2008 Dec; 42(12):799-805. PubMed ID: 18762767
[TBL] [Abstract][Full Text] [Related]
2. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.
Mahindra A; Bolwell B; Sobecks R; Rybicki L; Pohlman B; Dean R; Andresen S; Sweetenham J; Kalaycio M; Copelan E
Br J Haematol; 2009 Aug; 146(3):310-6. PubMed ID: 19508292
[TBL] [Abstract][Full Text] [Related]
3. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
[TBL] [Abstract][Full Text] [Related]
4. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Kataoka K; Nannya Y; Hangaishi A; Imai Y; Chiba S; Takahashi T; Kurokawa M
Biol Blood Marrow Transplant; 2009 Feb; 15(2):195-204. PubMed ID: 19167679
[TBL] [Abstract][Full Text] [Related]
5. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
Kim YR; Kim JS; Cheong JW; Song JW; Min YH
Acta Haematol; 2008; 120(3):182-9. PubMed ID: 19129689
[TBL] [Abstract][Full Text] [Related]
6. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation.
Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Yağci M
Transplant Proc; 2010 Jun; 42(5):1841-8. PubMed ID: 20620535
[TBL] [Abstract][Full Text] [Related]
7. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
Lim ZY; Fiaccadori V; Gandhi S; Hayden J; Kenyon M; Ireland R; Marsh J; Ho AY; Mufti GJ; Pagliuca A
Leuk Res; 2010 Jun; 34(6):723-7. PubMed ID: 19944463
[TBL] [Abstract][Full Text] [Related]
8. Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for lymphoma.
Mahindra A; Bolwell B; Sobecks R; Rybicki L; Pohlman B; Dean R; Andresen S; Sweetenham J; Kalaycio M; Copelan E
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1239-44. PubMed ID: 18940678
[TBL] [Abstract][Full Text] [Related]
9. Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation.
Dadwal SS; Tegtmeier B; Liu X; Frankel P; Ito J; Forman SJ; Pullarkat V
Eur J Haematol; 2015 Mar; 94(3):235-42. PubMed ID: 25082161
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.
Majhail NS; DeFor T; Lazarus HM; Burns LJ
Biol Blood Marrow Transplant; 2008 Jul; 14(7):790-4. PubMed ID: 18541198
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation.
Kanda J; Mizumoto C; Kawabata H; Ichinohe T; Tsuchida H; Tomosugi N; Matsuo K; Yamashita K; Kondo T; Ishikawa T; Uchiyama T
Biol Blood Marrow Transplant; 2009 Aug; 15(8):956-62. PubMed ID: 19589485
[TBL] [Abstract][Full Text] [Related]
12. Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation.
Chotsampancharoen T; Gan K; Kasow KA; Barfield RC; Hale GA; Leung W
Pediatr Transplant; 2009 May; 13(3):348-52. PubMed ID: 18518909
[TBL] [Abstract][Full Text] [Related]
13. Iron overload in hematopoietic cell transplantation.
Majhail NS; Lazarus HM; Burns LJ
Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425
[TBL] [Abstract][Full Text] [Related]
14. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
[TBL] [Abstract][Full Text] [Related]
15. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation.
Altès A; Remacha AF; Sureda A; Martino R; Briones J; Canals C; Brunet S; Sierra J; Gimferrer E
Bone Marrow Transplant; 2002 Jun; 29(12):987-9. PubMed ID: 12098067
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation.
Wirk B; Klumpp TR; Ulicny J; Herman JH; Gajewski JL; Martin ME; Emmons RV; Mangan KF
Transfusion; 2008 Jan; 48(1):163-8. PubMed ID: 17900280
[TBL] [Abstract][Full Text] [Related]
17. Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation.
Sivgin S; Baldane S; Kaynar L; Kurnaz F; Pala C; Ozturk A; Cetin M; Unal A; Eser B
Neoplasma; 2012; 59(2):183-90. PubMed ID: 22248276
[TBL] [Abstract][Full Text] [Related]
18. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
Kalantar-Zadeh K; Don BR; Rodriguez RA; Humphreys MH
Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181
[TBL] [Abstract][Full Text] [Related]
19. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality.
Poutsiaka DD; Price LL; Ucuzian A; Chan GW; Miller KB; Snydman DR
Bone Marrow Transplant; 2007 Jul; 40(1):63-70. PubMed ID: 17468772
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.
Meyer SC; O'Meara A; Buser AS; Tichelli A; Passweg JR; Stern M
Biol Blood Marrow Transplant; 2013 Mar; 19(3):440-4. PubMed ID: 23089566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]